Expertise in
9
conditions

Dr. David M. Baratz

Pulmonary Medicine
Pulmonary Associates
2000 S Thompson St, 
Flagstaff, AZ 
Accepting New Patients
Offers Telehealth
37 Years of Experience
Expertise in
9
conditions
Pulmonary Associates
2000 S Thompson St, 
Flagstaff, AZ 

Overview

David Baratz is a Pulmonary Medicine provider practicing medicine in Flagstaff, Arizona. He has been practicing medicine for over 37 years.

Dr. Baratz is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Obstructive Sleep Apnea, Narcolepsy, Lung Metastases, and Chronic Obstructive Pulmonary Disease (COPD).

Dr. Baratz is board certified in American Board Of Internal Medicine. He is actively involved in clinical research, co-authoring 1 peer reviewed article and participating in 5 clinical trials. Dr. Baratz is currently accepting new patients.

Specialties

Pulmonary Medicine

Licenses

Internal Medicine in AZ

Board Certifications

American Board Of Internal Medicine

Fellowships

Cedars-Sinai Medical Center

Hospital Affiliations

Honorhealth Scottsdale Shea Medical Center
Honorhealth Scottsdale Thompson Peak Med Ctr
Honor Health John C. Lincoln Medical Center

Languages Spoken

English
Russian

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
MercyCare
  • EPO
  • HMO
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Oscar
  • EPO
  • HMO
  • PPO
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VibrantRx
  • MEDICARE PDP
  • OTHER MEDICARE
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 21 Less Insurance Carriers -

Locations

Pulmonary Associates
2000 S Thompson St, Flagstaff, AZ 86001

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Compare the Efficacy and Safety of Sotatercept Versus Placebo When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Compare the Efficacy and Safety of Sotatercept Versus Placebo When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug, Biological
Study Drug: Sotatercept
Study Phase: Phase 3
A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study to Compare the Efficacy and Safety of Sotatercept (ACE-011) Versus Placebo When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH)
A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study to Compare the Efficacy and Safety of Sotatercept (ACE-011) Versus Placebo When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH)
Enrollment Status: Completed
Publish Date: April 19, 2023
Intervention Type: Drug, Other
Study Drug: Sotatercept
Study Phase: Phase 2
A Randomized, Phase 2, Open-Label, Multicenter Study to Evaluate the Safety, Tolerability, and Activity of Belumosudil in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
A Randomized, Phase 2, Open-Label, Multicenter Study to Evaluate the Safety, Tolerability, and Activity of Belumosudil in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment Status: Completed
Publish Date: September 08, 2022
Intervention Type: Other, Drug
Study Drug: KD025
Study Phase: Phase 2
A Phase 2a, Double-Blind, Placebo-Controlled Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of RVT-1201 in Patients With Pulmonary Arterial Hypertension
A Phase 2a, Double-Blind, Placebo-Controlled Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of RVT-1201 in Patients With Pulmonary Arterial Hypertension
Enrollment Status: Terminated
Publish Date: March 09, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 3 Less Clinical Trials

1 Total Publications

A Phase I Study of TRK-250, a Novel siRNA-Based Oligonucleotide, in Patients with Idiopathic Pulmonary Fibrosis.
A Phase I Study of TRK-250, a Novel siRNA-Based Oligonucleotide, in Patients with Idiopathic Pulmonary Fibrosis.
Journal: Journal of aerosol medicine and pulmonary drug delivery
Published: September 22, 2023
Similar Doctors
Expertise in
26
conditions
Dr. Yu Y. Huang
Pulmonary Medicine
Expertise in
26
conditions
Dr. Yu Y. Huang
Pulmonary Medicine
Referral may be required

Flagstaff Medical Center

1200 N Beaver St, 
Flagstaff, AZ 
 (2.4 miles away)
928-779-3366
Languages Spoken:
English, Mandarin, Twi
See accepted insurances
Accepting New Patients
Offers Telehealth

Yu Huang is a Pulmonary Medicine provider practicing medicine in Flagstaff, Arizona. Dr. Huang is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Lung Nodules, Asthma, Lung Metastases, and Pneumonia. Dr. Huang is currently accepting new patients.

Expertise in
9
conditions
Dr. Douglas W. Mapel
Pulmonary Medicine
Expertise in
9
conditions
Dr. Douglas W. Mapel
Pulmonary Medicine
Referral may be required
Before you request

Northern Arizona Pulmonary Associates LLC

1360 N Rim Dr, 
Flagstaff, AZ 
 (2.3 miles away)
928-774-8000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Douglas Mapel is a Pulmonary Medicine provider practicing medicine in Flagstaff, Arizona. Dr. Mapel is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Pulmonary Fibrosis, Silicosis, and Gastrostomy. Dr. Mapel is currently accepting new patients.

Expertise in
24
conditions
Dr. Sergio Fernando
Cardiology | Pulmonary Medicine
Expertise in
24
conditions
Dr. Sergio Fernando
Cardiology | Pulmonary Medicine
Referral may be required
Before you request

YRMG PC CM2 Cardiology

7700 E Florentine Rd Bldg B Ste 206, 
Prescott Valley,, AZ 
 (52.6 miles away)
928-227-5885
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Sergio Fernando is a Cardiologist and a Pulmonary Medicine provider practicing medicine in Prescott Valley,, Arizona. Dr. Fernando is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Dilated Cardiomyopathy (DCM), Cardiomyopathy, Carotid Artery Disease, and Defective Apolipoprotein B-100. Dr. Fernando is currently accepting new patients.

Frequently Asked Questions about Dr. David M. Baratz

How do I make an appointment with Dr. David M. Baratz?

You can book an appointment with Dr. David M. Baratz by calling their office at 928-226-6429. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. David M. Baratz a top-rated expert for Obstructive Sleep Apnea?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. David M. Baratz is classified as an Advanced expert for Obstructive Sleep Apnea, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. David M. Baratz specialize in?

While Dr. David M. Baratz is a Pulmonary Medicine, they have specific expertise in Obstructive Sleep Apnea, Narcolepsy, and Lung Metastases. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pulmonary Medicine.

Does Dr. David M. Baratz participate in research or clinical trials?

Yes. Dr. David M. Baratz has published 1 articles and abstracts on conditions like Obstructive Sleep Apnea. You can view a list of Dr. David M. Baratz's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. David M. Baratz accept my insurance?

Dr. David M. Baratz accepts most major insurance plans, including Aetna and Alignment Health Plan. We recommend calling the office directly at 928-226-6429 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Baratz's expertise for a condition
ConditionClose
      View All 9 Advanced Conditions
      View All 22 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile